FullHope BiomedicalLtd (TPEX:7773) - Stock Price, News & Analysis

7773 Stock Overview

Engages in the research and development of immune system-related services. More details

7773 fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Has not reported any financial data

Highly volatile share price over the past 3 months compared to the TW market

Does not have a meaningful market cap (NT$2B)

FullHope Biomedical Co.,Ltd. Competitors

UBI Pharma

TPEX:6562

NT$1.7b

Allied Biotech

TPEX:1780

NT$1.6b

Great Novel Therapeutics Biotech & Medicals

TPEX:7427

NT$1.6b

GenMont Biotech Incorporation

TWSE:3164

NT$1.7b

Price History & Performance

Summary of all time highs, changes and price drops for FullHope BiomedicalLtd
Historical stock prices
Current Share Price	NT$41.00
52 Week High	NT$70.30
52 Week Low	NT$38.50
Beta	0
11 Month Change	-18.16%
3 Month Change	n/a
1 Year Change	n/a
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	-25.32%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	7773	TW Biotechs	TW Market
7D	-2.0%	-3.1%	-0.8%
1Y	n/a	2.0%	29.0%

Return vs Industry: Insufficient data to determine how 7773 performed against the TW Biotechs industry.

Return vs Market: Insufficient data to determine how 7773 performed against the TW Market.

Price Volatility

Is 7773's price volatile compared to industry and market?
7773 volatility
7773 Average Weekly Movement	12.0%
Biotechs Industry Average Movement	4.5%
Market Average Movement	4.5%
10% most volatile stocks in TW Market	8.0%
10% least volatile stocks in TW Market	2.1%

Stable Share Price: 7773's share price has been volatile over the past 3 months compared to the TW market.

Volatility Over Time: Insufficient data to determine 7773's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2012	n/a	n/a	www.fhb.com.tw

FullHope Biomedical Co.,Ltd. engages in the research and development of immune system-related services. It develops FHCT001 and FHCT003, an immune cell therapies for cancer; and FHCT002, an auto-immune cell therapy, as well as diagnostic tools.

FullHope Biomedical Co.,Ltd. Fundamentals Summary

How do FullHope BiomedicalLtd's earnings and revenue compare to its market cap?
7773 fundamental statistics
Market cap	NT$1.64b
Earnings (TTM)	NT$0
Revenue (TTM)	n/a

n/a

P/E Ratio

n/a

P/S Ratio

Is 7773 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
7773 income statement (TTM)
Revenue	NT$0
Cost of Revenue	NT$0
Gross Profit	NT$0
Other Expenses	NT$0
Earnings	NT$0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did 7773 perform over the long term?

See historical performance and comparison